Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
Ozempic. Wegovy and other GLP-1 medications have been hailed as groundbreaking treatments for individuals struggling with ...
Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.
Six percent of Americans have used Ozempic, Wegovy and similar drugs. They’re unwitting experimental subjects.
The manufacturer of the weight loss jab Wegovy has been reprimanded for allegedly failing to disclose or accurately report ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...